Mayne Pharma Group Balance Sheet Health
Financial Health criteria checks 6/6
Mayne Pharma Group has a total shareholder equity of A$547.8M and total debt of A$30.0M, which brings its debt-to-equity ratio to 5.5%. Its total assets and total liabilities are A$1.2B and A$604.9M respectively.
Key information
5.5%
Debt to equity ratio
AU$30.02m
Debt
| Interest coverage ratio | n/a |
| Cash | AU$154.81m |
| Equity | AU$547.77m |
| Total liabilities | AU$604.88m |
| Total assets | AU$1.15b |
Recent financial health updates
Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?
Dec 01
Is Mayne Pharma Group (ASX:MYX) A Risky Investment?
Apr 12Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt
Nov 10Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt
May 17Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?
Dec 09
Recent updates
Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade
Mar 06Analysts Just Slashed Their Mayne Pharma Group Limited (ASX:MYX) EPS Numbers
Dec 03Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?
Dec 01Is Mayne Pharma Group (ASX:MYX) A Risky Investment?
Apr 12Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade
Mar 01We Think Mayne Pharma Group Limited's (ASX:MYX) CEO Compensation Package Needs To Be Put Under A Microscope
Nov 16Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt
Nov 10Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt
May 17Is Mayne Pharma Group Limited (ASX:MYX) Trading At A 37% Discount?
Mar 22How Many Mayne Pharma Group Limited (ASX:MYX) Shares Did Insiders Buy, In The Last Year?
Mar 01What You Need To Know About Mayne Pharma Group Limited's (ASX:MYX) Investor Composition
Feb 08Mayne Pharma Group Limited's (ASX:MYX) Shift From Loss To Profit
Jan 18Mayne Pharma Group's (ASX:MYX) Shareholders Are Down 75% On Their Shares
Dec 27Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?
Dec 09A Quick Analysis On Mayne Pharma Group's (ASX:MYX) CEO Compensation
Nov 24Financial Position Analysis
Short Term Liabilities: MYX's short term assets (A$475.3M) exceed its short term liabilities (A$295.7M).
Long Term Liabilities: MYX's short term assets (A$475.3M) exceed its long term liabilities (A$309.2M).
Debt to Equity History and Analysis
Debt Level: MYX has more cash than its total debt.
Reducing Debt: MYX's debt to equity ratio has reduced from 30.4% to 5.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MYX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MYX has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 48.2% each year.